ArticleAbdominal radiology (New York)2025
Computed tomography-based delta-radiomics analysis for preoperative prediction of ISUP pathological nuclear grading in clear cell renal cell carcinoma.
Article in Abdominal radiology (New York), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundNuclear grading of clear cell renal cell carcinoma (ccRCC) plays a crucial role in diagnosing and managing the disease.
objectiveTo develop and validate a CT-based Delta-Radiomics model for preoperative assessment of nuclear grading in renal clear cell carcinoma. MATERIALS AND
methodsThis retrospective analysis included surgical cases of 146 ccRCC patients from two medical centers from December 2018 to December 2023, with 117 patients from Hospital and 29 from the *Hospital Affiliated to University of **. Radiomic features were extracted from whole-abdomen CT images, and the Least Absolute Shrinkage and Selection Operator (LASSO) algorithm was used for feature selection. The Multi-Layer Perceptron (MLP) approach was employed to construct five predictive models (RAD_NE, RAD_AP, RAD_VP, RAD_Delta1, RAD_Delta2). The models were evaluated using area under the curve (AUC), accuracy, sensitivity, and specificity, while clinical utility was assessed through Decision Curve Analysis (DCA).
resultsA total of 1,834 radiomic features were extracted from the three phases of the CT images for each model. The models demonstrated strong classification performance, with AUC values ranging from 0.837 to 0.911 in the training set and 0.608 to 0.869 in the test set. The Rad_Delta1 and Rad_Delta2 models demonstrated advantages in predicting ccRCC pathological grading.The AUC value of the Rad_Delta1 is 0.911in the training set and 0.771 in the external verifcation set.The AUC value of the Rad_Delta2 is 0.881 in the training set and0.608 in the external verifcation set. DCA curves confirmed the clinical applicability of these models.
conclusionCT-based delta-radiomics shows potential in predicting the pathological grading of clear cell renal cell carcinoma (ccRCC).
Indexed as
Identifiers
40024922What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.